As Head, Laboratory Research of IHVN, Dr. Nicaise Ndembi brings to IHVN, a wealth of knowledge in molecular virology, Clinical trials, HIV therapy, HIV drug resistance and bioinformatics. Dr. Ndembi has set up the Asokoro Laboratory Training Centre for genotyping (HLA-typing, HIV drug resistance testing, HCV, HBV and HPV genotyping). Dr. Ndembi , who was educated at University of Yaoundé-I, Cameroon and Kanazawa University, Japan, has a Ph.D in Molecular Virology and an MPhil and M.Sc in Biochemistry and Molecular Biology. Prior to his resumption in IHVN, he was the Head, Molecular Virology Laboratory, MRC/UVRI Research Unit on AIDS, Medical Research Council (UK), and Uganda Virus Research Institute. He has also worked in academic and managerial capacities in Japan and Cameroon. Dr. Ndembi has several national and international fellowships and grants to his credit, he has received a scholarship for PhD studies from the Japanese Ministry of Education, a senior Fellowship award from the European and Developing Clinical Trials Partnership (EDCTP), a vocational award from Rotary International and he is co-investigators on several NIH, MRC, CDC research grants. He is a member of the PharmAccess technical advisory board for resistance evaluation in Africa. He served as a consultant for the World Health Organization (WHO) for the WHO HIV ResNet Laboratory Working Group. Dr. Ndembi has authored and co-authored over 70 peer-reviewed publications in high impact factor journals (Lancet, Journal of Virology, PlosMedicine, AIDS, JID, Lancet of Infectious Diseases) and over 100 abstracts and proceedings. He is part of the senior research team that has isolated HIV-1 group O and HIV-1 group P (Vallari A, Holzmayer V, Harris B, Yamaguchi J, Ngansop C, Makamche F, Mbanya D, Kaptué L, Ndembi N, Gürtler L, Devare S, Brennan CA. Confirmation of putative HIV-1 group P in Cameroon. J Virol. 2011 Feb;85(3):1403-7.) and member of the DART Virology clinical trial group in Africa.
Biography Updated on 3 September 2013